PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.76%
Negative revenue growth while 0354.HK stands at 6.33%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
2.97%
Positive gross profit growth while 0354.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
71.06%
Operating income growth above 1.5x 0354.HK's 0.25%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
136.02%
Net income growth above 1.5x 0354.HK's 19.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
135.09%
EPS growth above 1.5x 0354.HK's 8.81%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
135.09%
Diluted EPS growth above 1.5x 0354.HK's 16.97%. David Dodd would see if there's a robust moat protecting these shareholder gains.
2.81%
Share reduction more than 1.5x 0354.HK's 7.54%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
2.75%
Diluted share count expanding well above 0354.HK's 1.96%. Michael Burry would fear significant dilution to existing owners' stakes.
2829.79%
Dividend growth of 2829.79% while 0354.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-472.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-449.59%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
18.49%
10Y revenue/share CAGR under 50% of 0354.HK's 264.39%. Michael Burry would suspect a lasting competitive disadvantage.
3.24%
5Y revenue/share CAGR under 50% of 0354.HK's 114.08%. Michael Burry would suspect a significant competitive gap or product weakness.
23.17%
3Y revenue/share CAGR under 50% of 0354.HK's 67.84%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-1171.24%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-39.56%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-452.60%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-97.91%
Negative 10Y net income/share CAGR while 0354.HK is at 42.91%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-96.95%
Negative 5Y net income/share CAGR while 0354.HK is 163.50%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-95.95%
Negative 3Y CAGR while 0354.HK is 90.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
22.47%
Below 50% of 0354.HK's 86.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
8.51%
Below 50% of 0354.HK's 54.22%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-75.69%
Negative 5Y dividend/share CAGR while 0354.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-57.17%
Negative near-term dividend growth while 0354.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.99%
AR growth is negative/stable vs. 0354.HK's 22.21%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-19.74%
Inventory is declining while 0354.HK stands at 160.85%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.06%
Negative asset growth while 0354.HK invests at 7.33%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.52%
We have a declining book value while 0354.HK shows 2.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
17.00%
Debt growth far above 0354.HK's 12.88%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-16.72%
We cut SG&A while 0354.HK invests at 52.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.